JB Chemicals launches 'Auster'

New Delhi, July 10 (UNI) JB Chemicals and Pharmaceuticals today announced the launch of new speciality division 'Auster', primarily focusing on therapeutic segments of Cardiology, Orthopedic and Gastroentrology.

''The company will promote and market the brands through its own marketing team using its strength in these core areas,'' JB Chemicals Chairman and Managing Director J B Mody said.

JB Chemicals and Pharmaceuticals (JBCPL), a global pharmaceutical company is engaged in manufacturing and markets a wide range of pharmaceutical formulations, herbal remedies, bulk drugs, intermediates and radio-diagnostics.

Currently the total market size of Cardiology, Orthopedic and Gastroentrology is Rs 2,900 crore, as per AC Nielsen ORG-MARG, and the same is growing by more than 16 per cent per annum.

UNI DKS VJ HS2021